#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ornithine transcarbamoylase deficiency Myelin oligodendrocyte glycoprotein antibody-associated disease B-cell small lymphocytic lymphoma recurrent Hairy cell leukaemia Antithrombin III deficiency Albright's disease Hormone-dependent prostate cancer Neonatal alloimmune thrombocytopenia Angiosarcoma recurrent Henoch-Schonlein purpura nephritis Transitional cell carcinoma Colitis ulcerative Inclusion body myositis Glioblastoma multiforme Osteosarcoma metastatic More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Life with Disease Shprintzen-Goldberg syndrome – Life with Disease Retinoblastoma – Trials in Disease Testicular leiomyosarcoma – Basic Information Congenital generalised lipodystrophy Haemophilia A with anti factor VIII – Basic Information Isodicentric chromosome 15 syndrome – Life with Disease Mucopolysaccharidosis Skin angiosarcoma – Diagnostics Haemophilia B with anti factor IX – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-PROLINE ADS-019 Fluorouracil Sodium SGT-003 Op-1250 Phleum Pratense Edotreotide Acoramidis Senicapoc Buprenorphine Mps-213 Goserelin 177Lu-Dpi-4452 Sunitinib Methyl Aminolevulinate Aup1602-C Davutamig Insulin Human Treosulfan Omp66 More therapies…

    Learn about Your Condition

    Procedural hypotension Milk allergy Plasma cell myeloma Alcoholism Oesophageal atresia Dupuytren's contracture Retinoblastoma Thrombotic microangiopathy Noninfective chorioretinitis Cytokine release syndrome Netherton's syndrome Adrenocortical carcinoma Postprandial hypoglycaemia Prostate cancer Infectious pleural effusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Comparing piperacillin-tazobactam and meropenem for treating bloodstream infections caused by cephalosporin-resistant bacteria in adult patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacteraemia
    Investigated Drugs:
    • Meropenem Anhydrous
    • Piperacillin
    • Tazobactam
    Italy

  • Comparing rifampin-free treatment versus rifampin in adults with staphylococcal prosthetic valve endocarditis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • CEFTAROLINE FOSAMIL
    • Daptomycin
    • Levofloxacin
    France

  • Comparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules

    Recruiting

    3 1 1 1
    Spain

  • Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fungal infection
    Investigated Drugs:
    • Anidulafungin
    • Caspofungin Acetate
    • FOSMANOGEPIX
    Austria Belgium France Germany Greece Italy +2

  • Study of cefadroxil effectiveness in adult patients with Staphylococcus aureus bloodstream infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Belgium

  • Study evaluating blood biomarkers for diagnosis and monitoring treatment in patients with pulmonary tuberculosis using isoniazid, rifampicin, pyrazinamide, and ethambutol combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Ethambutol Hydrochloride
    • Isoniazid
    • Pyrazinamide
    Spain
Previous Page
1 … 3 4 5 6 7 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!